共 13 条
[1]
Van Eldere J., Slack M.P., Ladhani S., Cripps A.W., Non-typeable Haemophilus influenzae, an under-recognised pathogen, Lancet Infect Dis., 14, 12, pp. 1281-1292, (2014)
[2]
Leach A.J., Wigger C., Beissbarth J., Woltring D., Andrews R., Chatfield M.D., Et al., General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines, Int J Pediatr Otorhinolaryngol, 86, pp. 224-232, (2016)
[3]
Smith-Vaughan H.C., Binks M.J., Marsh R.L., Kaestli M., Ward L., Hare K.M., Et al., Dominance of Haemophilus influenzae in ear discharge from Indigenous Australian children with acute otitis media with tympanic membrane perforation, BMC Ear Nose Throat Disord., 13, 1, (2013)
[4]
Hare K.M., Grimwood K., Leach A.J., Smith-Vaughan H., Torzillo P.J., Morris P.S., Et al., Respiratory bacterial pathogens in the nasopharynx and lower airways of Australian indigenous children with bronchiectasis, J Pediatr, 157, 6, pp. 1001-1005, (2010)
[5]
Sethi S., Murphy T.F., Bacterial infection in chronic obstructive pulmonary disease in 2000: A state-of-the-art review, Clin Microbiol Rev, 14, 2, pp. 336-363, (2001)
[6]
Murphy T.F., Brauer A.L., Sethi S., Kilian M., Cai X., Lesse A.J., Haemophilus haemolyticus: A human respiratory tract commensal to be distinguished from Haemophilus influenzae, J Infect Dis, 195, 1, pp. 81-89, (2007)
[7]
Zhang B., Kunde D., Tristram S., Haemophilus haemolyticus is infrequently misidentified as Haemophilus influenzae in diagnostic specimens in Australia, Diagn Microbiol Infect Dis, 80, 4, pp. 272-273, (2014)
[8]
Kirkham L.A., Wiertsema S.P., Mowe E.N., Bowman J.M., Riley T.V., Richmond P.C., Nasopharyngeal carriage of Haemophilus haemolyticus in otitis-prone and healthy children, J Clin Microbiol, 48, 7, pp. 2557-2559, (2010)
[9]
Leach A.J., Wigger C., Andrews R., Chatfield M., Smith-Vaughan H., Morris P.S., Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules, BMC Pediatr., 14, (2014)
[10]
Leach A.J., Mulholland E.K., Santosham M., Torzillo P.J., Brown N.J., McIntyre P., Et al., Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX-COMBO): Protocol of a randomised controlled trial, BMJ Open, 5, 1, (2015)